Works by Liu, Wenyu

Results: 172
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    The pan-genome and local adaptation of Arabidopsis thaliana.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42029-4
    By:
    • Kang, Minghui;
    • Wu, Haolin;
    • Liu, Huanhuan;
    • Liu, Wenyu;
    • Zhu, Mingjia;
    • Han, Yu;
    • Liu, Wei;
    • Chen, Chunlin;
    • Song, Yan;
    • Tan, Luna;
    • Yin, Kangqun;
    • Zhao, Yusen;
    • Yan, Zhen;
    • Lou, Shangling;
    • Zan, Yanjun;
    • Liu, Jianquan
    Publication type:
    Article
    11

    Evolutionary origin of genomic structural variations in domestic yaks.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41220-x
    By:
    • Liu, Xinfeng;
    • Liu, Wenyu;
    • Lenstra, Johannes A.;
    • Zheng, Zeyu;
    • Wu, Xiaoyun;
    • Yang, Jiao;
    • Li, Bowen;
    • Yang, Yongzhi;
    • Qiu, Qiang;
    • Liu, Hongyu;
    • Li, Kexin;
    • Liang, Chunnian;
    • Guo, Xian;
    • Ma, Xiaoming;
    • Abbott, Richard J.;
    • Kang, Minghui;
    • Yan, Ping;
    • Liu, Jianquan
    Publication type:
    Article
    12
    13
    14

    Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16 , 998.

    Published in:
    2024
    By:
    • Chisholm, Julia;
    • Mandeville, Henry;
    • Adams, Madeleine;
    • Minard-Collin, Veronique;
    • Rogers, Timothy;
    • Kelsey, Anna;
    • Shipley, Janet;
    • van Rijn, Rick R.;
    • de Vries, Isabelle;
    • van Ewijk, Roelof;
    • de Keizer, Bart;
    • Gatz, Susanne A.;
    • Casanova, Michela;
    • Hjalgrim, Lisa Lyngsie;
    • Firth, Charlotte;
    • Wheatley, Keith;
    • Kearns, Pamela;
    • Liu, Wenyu;
    • Kirkham, Amanda;
    • Rees, Helen
    Publication type:
    Correction Notice
    15

    Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

    Published in:
    Cancers, 2024, v. 16, n. 5, p. 998, doi. 10.3390/cancers16050998
    By:
    • Chisholm, Julia;
    • Mandeville, Henry;
    • Adams, Madeleine;
    • Minard-Collin, Veronique;
    • Rogers, Timothy;
    • Kelsey, Anna;
    • Shipley, Janet;
    • van Rijn, Rick R.;
    • de Vries, Isabelle;
    • van Ewijk, Roelof;
    • de Keizer, Bart;
    • Gatz, Susanne A.;
    • Casanova, Michela;
    • Hjalgrim, Lisa Lyngsie;
    • Firth, Charlotte;
    • Wheatley, Keith;
    • Kearns, Pamela;
    • Liu, Wenyu;
    • Kirkham, Amanda;
    • Rees, Helen
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 446, doi. 10.1016/j.clml.2023.02.009
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Lin, Tung-Liang;
    • Chim, Chor Sang;
    • Qi, Ming;
    • Wang, Jianping;
    • Lu, Xiaolin;
    • Song, Yang;
    • Jia, Bin;
    • Yang, Xue;
    • Liu, Wenyu;
    • Zhou, Tianyuan
    Publication type:
    Article
    45
    46

    P-163: Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S125, doi. 10.1016/S2152-2650(21)02290-4
    By:
    • Weijun Fu;
    • Honghui Huang;
    • Wei Li;
    • Gang An;
    • Zhen Cai;
    • Jie Jin;
    • Yafei Wang;
    • Chor Sang Chim;
    • Ming Qi;
    • Jianping Wang;
    • Yang Song;
    • Bin Jia;
    • Xue Yang;
    • Wenyu Liu;
    • Yunan Li;
    • Renyi Zhang;
    • Jian Hou;
    • Jianxiang Wang
    Publication type:
    Article
    47

    Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e699, doi. 10.1016/j.clml.2021.04.012
    By:
    • Lu, Jin;
    • Fu, Weijun;
    • Li, Wei;
    • Hu, Jianda;
    • An, Gang;
    • Wang, Yafei;
    • Fu, Chengcheng;
    • Chen, Lijuan;
    • Jin, Jie;
    • Cen, Xinan;
    • Ge, Zheng;
    • Cai, Zhen;
    • Niu, Ting;
    • Qi, Ming;
    • Sun, Steven;
    • Gai, Xue;
    • Liu, Weiping;
    • Liu, Wenyu;
    • Yang, Xue;
    • Huang, Xiaojun
    Publication type:
    Article
    48
    49
    50